C3 and myeloid sarcoma: Moreover, elevated levels of plasma C3, C4, C4a, C1 inhibitor, factor H, and reduced levels of C9 have been found in MS patients [10–13], as well as increased cerebrospinal fluid (CSF) C4b and alterations in C3 [14–16].